Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Sep 30)
Earnings Recap
Galectin Therapeutics (NASDAQ:GALT) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Galectin Therapeutics missed estimated earnings by 50.0%, reporting an EPS of $-0.24 versus an estimate of $-0.16.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06 which was followed by a 7.38% increase in the share price the next day.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/2023 | AM | GALT | Q3 | -$0.14 | -$0.16 | -$0.24 | -50.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2023 | AM | GALT | Q2 | -$0.16 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
| 05/15/2023 | AM | GALT | Q1 | -$0.17 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | Get Alert |
| 03/30/2023 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $0.00 | — | Get Alert |
| 11/14/2022 | AM | GALT | Q3 | -$0.14 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/15/2022 | AM | GALT | Q2 | -$0.15 | -$0.21 | -$0.16 | 23.81% | $0.00 | — | $0.00 | — | Get Alert |
| 05/16/2022 | AM | GALT | Q1 | -$0.11 | -$0.14 | -$0.17 | -21.43% | $0.00 | — | $0.00 | — | Get Alert |
| 03/31/2022 | AM | GALT | Q4 | -$0.13 | -$0.19 | -$0.12 | 36.84% | $0.00 | — | $0.00 | — | Get Alert |
| 11/15/2021 | AM | GALT | Q3 | -$0.10 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 08/16/2021 | AM | GALT | Q2 | -$0.11 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 05/17/2021 | AM | GALT | Q1 | -$0.06 | -$0.17 | -$0.11 | 35.29% | $0.00 | — | $0.00 | — | Get Alert |
| 03/31/2021 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | Get Alert |
| 11/09/2020 | AM | GALT | Q3 | -$0.05 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2020 | AM | GALT | Q2 | -$0.06 | -$0.09 | -$0.11 | -22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2020 | AM | GALT | Q1 | -$0.20 | -$0.09 | -$0.06 | 33.33% | $0.00 | — | $0.00 | — | Get Alert |
| 03/16/2020 | AM | GALT | Q4 | -$0.08 | — | -$0.12 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/12/2019 | AM | GALT | Q3 | -$0.07 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/09/2019 | AM | GALT | Q2 | -$0.11 | — | -$0.06 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/10/2019 | AM | GALT | Q1 | -$0.12 | -$0.14 | -$0.20 | -42.86% | $0.00 | — | $0.00 | — | Get Alert |
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics (GALT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3.
What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?
Galectin Therapeutics (GALT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3 and the Actual EPS was $-0.24, which missed the estimate of $-0.16.
What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?
Galectin Therapeutics (GALT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.